Silvia García‐Vicente

Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner

A. Abella, Silvia García‐Vicente, Nathalie Viguerie et al. · Diabetologia · 2004 · 109 citations · Full text

Inflammation, Signal Transduction, Biochemistry +14

Oral Insulin-Mimetic Compounds That Act Independently of Insulin

Silvia García‐Vicente, Francesc Yraola, Luc Marti et al. · Diabetes · 2007 · 66 citations

Metabolic Syndrome, Medicinal Chemistry, Biochemistry +14

Arylalkylamine vanadium salts as new anti-diabetic compounds

António Zorzano, Manuel Palacı́n, Luc Marti et al. · Journal of Inorganic Biochemistry · 2009 · 50 citations

Medicine, Diabetes, Arylalkylamine Vanadium Salts +2

Understanding the Mechanism of Action of the Novel SSAO Substrate (C₇NH₁₀)₆(V₁₀O₂₈)·2H₂O, a Prodrug of Peroxovanadate Insulin Mimetics

Francesc Yraola, Silvia García‐Vicente, Luc Marti et al. · Chemical Biology & Drug Design · 2007 · 44 citations

New Efficient Substrates for Semicarbazide-Sensitive Amine Oxidase/VAP-1 Enzyme:  Analysis by SARs and Computational Docking

Francesc Yraola, Silvia García‐Vicente, Juan Fernández‐Recio et al. · Journal of Medicinal Chemistry · 2006 · 37 citations

Proteinlipid Interaction, Ssao Substrate Selectivity, Cell Adhesion +17